These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1150 related items for PubMed ID: 14635068
1. The percentage of prostate needle biopsy cores with carcinoma from the more involved side of the biopsy as a predictor of prostate specific antigen recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database. Freedland SJ, Aronson WJ, Terris MK, Kane CJ, Amling CL, Dorey F, Presti JC. Cancer; 2003 Dec 01; 98(11):2344-50. PubMed ID: 14635068 [Abstract] [Full Text] [Related]
2. Percent of prostate needle biopsy cores with cancer is significant independent predictor of prostate specific antigen recurrence following radical prostatectomy: results from SEARCH database. Freedland SJ, Aronson WJ, Terris MK, Kane CJ, Amling CL, Dorey F, Presti JC, SEARCH Database Study Group. J Urol; 2003 Jun 01; 169(6):2136-41. PubMed ID: 12771735 [Abstract] [Full Text] [Related]
3. Improved risk stratification for biochemical recurrence after radical prostatectomy using a novel risk group system based on prostate specific antigen density and biopsy Gleason score. Freedland SJ, Wieder JA, Jack GS, Dorey F, deKernion JB, Aronson WJ. J Urol; 2002 Jul 01; 168(1):110-5. PubMed ID: 12050502 [Abstract] [Full Text] [Related]
5. Comparison of preoperative prostate specific antigen density and prostate specific antigen for predicting recurrence after radical prostatectomy: results from the search data base. Freedland SJ, Kane CJ, Presti JC, Terris MK, Amling CL, Dorey F, Aronson WJ. J Urol; 2003 Mar 01; 169(3):969-73. PubMed ID: 12576824 [Abstract] [Full Text] [Related]
6. Percentage of positive biopsy cores, preoperative prostate-specific antigen (PSA) level, pT and Gleason score as predictors of PSA recurrence after radical prostatectomy: a multi-institutional outcome study in Japan. Yokomizo A, Murai M, Baba S, Ogawa O, Tsukamoto T, Niwakawa M, Tobisu K, Kinukawa N, Naito S. BJU Int; 2006 Sep 01; 98(3):549-53. PubMed ID: 16925752 [Abstract] [Full Text] [Related]
8. External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores. Kupelian P, Katcher J, Levin H, Zippe C, Suh J, Macklis R, Klein E. Cancer J Sci Am; 1997 Sep 01; 3(2):78-87. PubMed ID: 9099457 [Abstract] [Full Text] [Related]
9. Percent of cores positive for cancer is a better preoperative predictor of cancer recurrence after radical prostatectomy than prostate specific antigen. San Francisco IF, Regan MM, Olumi AF, DeWolf WC. J Urol; 2004 Apr 01; 171(4):1492-9. PubMed ID: 15017206 [Abstract] [Full Text] [Related]
10. Percentages of positive cores, cancer length and Gleason grade 4/5 cancer in systematic sextant biopsy are all predictive of adverse pathology and biochemical failure after radical prostatectomy. Suekane S, Noguchi M, Nakashima O, Yamada S, Kojiro M, Matsuoka K. Int J Urol; 2007 Aug 01; 14(8):713-8. PubMed ID: 17681061 [Abstract] [Full Text] [Related]
11. Biochemical outcome after radical prostatectomy among men with normal preoperative serum prostate-specific antigen levels. Freedland SJ, Aronson WJ, Kane CJ, Terris MK, Presti JC, Trock B, Amling CL. Cancer; 2004 Aug 15; 101(4):748-53. PubMed ID: 15305405 [Abstract] [Full Text] [Related]
12. Percentage of cancer in prostate biopsies as prognostic factor for staging and postoperative biochemical failure after radical prostatectomy. Villamón-Fort R, Martínez-Jabaloyas JM, Soriano-Sarriá P, Ramos-Soler D, Pastor-Hernández F, Gil-Salom M. Urol Int; 2007 Aug 15; 78(4):328-33. PubMed ID: 17495491 [Abstract] [Full Text] [Related]
13. The extent of biopsy involvement as an independent predictor of extraprostatic extension and surgical margin status in low risk prostate cancer: implications for treatment selection. Gao X, Mohideen N, Flanigan RC, Waters WB, Wojcik EM, Leman CR. J Urol; 2000 Dec 15; 164(6):1982-6. PubMed ID: 11061896 [Abstract] [Full Text] [Related]
15. The correlation among the percentage of positive biopsy cores from the dominant side of prostate, adverse pathology, and biochemical failure after radical prostatectomy. Memis A, Ugurlu O, Ozden C, Oztekin CV, Aktas BK, Akdemir AO. Kaohsiung J Med Sci; 2011 Aug 15; 27(8):307-13. PubMed ID: 21802641 [Abstract] [Full Text] [Related]
16. Side-specific factors associated with extracapsular extension and seminal vesicular invasion in men undergoing open radical retropubic prostatectomy. Sankin A, Tareen B, Lepor H. Prostate Cancer Prostatic Dis; 2009 Aug 15; 12(2):204-8. PubMed ID: 19238170 [Abstract] [Full Text] [Related]
17. Perineural invasion as a predictor of biochemical outcome following radical prostatectomy for select men with clinically localized prostate cancer. D'Amico AV, Wu Y, Chen MH, Nash M, Renshaw AA, Richie JP. J Urol; 2001 Jan 15; 165(1):126-9. PubMed ID: 11125380 [Abstract] [Full Text] [Related]
18. Preoperative p27 status is an independent predictor of prostate specific antigen failure following radical prostatectomy. Freedland SJ, deGregorio F, Sacoolidge JC, Elshimali YI, Csathy GS, Dorey F, Reiter RE, Aronson WJ. J Urol; 2003 Apr 15; 169(4):1325-30. PubMed ID: 12629353 [Abstract] [Full Text] [Related]
20. The percentage of positive biopsy cores as a predictor of disease recurrence in patients with prostate cancer treated with radical prostatectomy. Antunes AA, Srougi M, Dall'Oglio MF, Crippa A, Campagnari JC, Leite KR. BJU Int; 2005 Dec 15; 96(9):1258-63. PubMed ID: 16287441 [Abstract] [Full Text] [Related] Page: [Next] [New Search]